Paul C Reiter

US Patent:

20090104630, Apr 23, 2009

Filed:

Oct 17, 2008

Appl. No.:

12/288180

Inventors:

Paul C. Reiter - East Hampstead NH, US

International Classification:

G01N 33/53
C12M 1/00

US Classification:

435 721, 4352872

Abstract:

A semi-quantitative, immunochromatographic device for the detection of HIV/AIDS immune status CD4+ T cell equivalents, such as soluble CD40 ligand/CD 154, includes one or more support materials capable of providing lateral flow. The one or more support materials include a first area for receiving a biological sample containing a target analyte, the analyte being a CD4+ T cell equivalent, such as soluble CD40 ligand/CD 154, a second area having a movably contained detector ligand, wherein the detector ligand is capable of forming a mobile complex with the soluble CD40 ligand/CD 154, and at least one capture area having a predetermined amount of an immobile capture reagent, the immobile capture reagent capable of specifically binding to the mobile complex formed by the soluble CD40 ligand/CD 154 protein and the detector ligand and providing a visible signal.

US Patent:

20090258343, Oct 15, 2009

Filed:

May 27, 2009

Appl. No.:

12/454951

Inventors:

Paul C. Reiter - East Hampstead NH, US

International Classification:

C12Q 1/70
C12M 1/00

US Classification:

435 5, 4352872

Abstract:

A semi-quantitative, immunochromatographic dual test device for the simultaneous detection of HIV/AIDS immune status CD4+ T cell equivalents, such as soluble CD40 ligand/CD 154, and the detection of an HIV antibody, includes one or more support materials capable of providing lateral flow. The one or more support materials include at least one sample receiving area for receiving a biological sample containing a first target analyte, the first target analyte being a CD4+ T cell equivalent, such as soluble CD40 ligand/CD 154, and a second target analyte, the second target analyte being an HIV antibody. A second area, situated on the one or more support materials, has a movably contained detector ligand and or detector antigens, wherein the detector ligand and or detector antigens is capable of forming a mobile complex with the soluble CD40 ligand/CD 154 and or HIV antibodies, and at least a first capture area having a predetermined amount of a first immobile capture reagent, the first immobile capture reagent capable of specifically binding to the mobile complex formed by the soluble CD40 ligand/CD 154 protein and the detector ligand and providing a visible signal. The one or more support materials further have situated thereon at least a second capture area having a predetermined amount of a second immobile capture reagent that is capable of specifically binding to HIV antibodies present in the biological sample and providing a visible signal.

US Patent:

44368208, Mar 13, 1984

Filed:

Feb 1, 1982

Appl. No.:

6/344404

Inventors:

Paul Reiter - Port Jefferson Station NY

International Classification:

G01N 3372

US Classification:

436 67

Abstract:

Method and apparatus for separating and measuring the amount of the glycosylated hemoglobin fractions in a blood sample. The method and apparatus provide a means for lysing sample red blood cells and, in the same container, separating the glycosylated hemoglobin fractions from the other residual hemoglobin fractions through the utilization of a polymeric material.